Speaker: Dr. Yanming Li from the University of Kansas Medical Center
Date and Time: Thursday, September 23, 2021, 2pm-3pm via Zoom. Please contact Qingning Zhou to obtain the Zoom link.
Title: Disease Prediction by Detecting and Integrating Connectomic Networks and Marginally Weak Signals
Abstract: Many contemporary studies use individual genomic or imaging profiles for early prediction of cancer or neuropsychological outcomes, such as cancer subtypes and Alzheimer’s disease stages. Current approaches base prediction using only biomarkers that are strongly correlated with the disease outcome. However, the connection structures of the genome and the brain (e.g. gene pathways or brain networks) are ignored in such marginal approaches. Many genetic and imaging markers, despite having marginally weak effects, may exude strong predictive effects once considered together with their connected biomarkers. Weak signals are not detectable by themselves because of their small marginal effect sizes. To find weak signals, the inter-feature connection (or network) structure of the genome or brain (which is termed the genome or brain connectome) has to be explored first. However, given the ultrahigh-dimensional characteristic of genomic/neuroimaging profiles, identifying the whole genome/brain connectome is computational prohibitive. This is also an impediment for detecting weak signals. In this work, we hypothesize that a large portion of the predictiveness of diseases attributes to inter-marker connections as well as marginally weak signals. By detecting and integrating them, accuracy of prediction can be significantly improved. We develop novel statistical/machine-learning algorithms for detecting connectomic genetic or brain networks for cancer or AD related outcome prediction. The proposed methods can be extended to detecting connectomic profiles for numerous outcome types using pan-cancer, pan-omic and multi-modality neuroimaging data. The identified network or pathway signatures will also enhance our understanding about the underlying mechanisms of disease development and progression.